ELAVL2 and glioblastoma: To characterize the transcriptomic signatures associated with ELAVL2 expression level, we first utilized parametric gene set enrichment analysis (PGSEA) using the gene expression profiles of ELAVL2-high and -low TCGA GBM patients (Fig. 3a).